Actemra 100mg, a drug known scientifically as tocilizumab, is a a potent biologic agent primarily employed for the treatment of rheumatoid arthritis. This effective agent functions by inhibiting the activity of interleukin-6 (IL-6), a signaling protein crucial in the inflammatory process. Moreover, Actemra demonstrates promise in the management of